Alignment Healthcare, INC Form 4 insider transactions

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, sold 1,821 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold 10,151 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold 4,299 shares of common stock on March 28, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 4,363 shares of common stock on March 28, 2024, to cover tax withholding obligations related to vesting restricted stock units.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, sold shares to cover tax withholding obligations related to a recent stock grant.

Robert L. Scavo, Chief Information Officer of Alignment Healthcare, sold 3,078 shares of common stock on March 19, 2024, to cover tax withholding obligations.

Christopher J. Joyce, Chief Legal and Admin. Officer of Alignment Healthcare, sold 25,060 shares of common stock to cover tax withholding obligations.

Hyong Kim, Chief Medical Officer of Alignment Healthcare, sold 5,576 shares of common stock to cover tax withholding obligations.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 18,964 shares of common stock on March 19, 2024, to cover tax withholding obligations related to a recent stock grant.

Robert Thomas Freeman, CFO of Alignment Healthcare, sold 28,522 shares of common stock on March 19, 2024, to cover tax withholding obligations.

Alignment Healthcare's CEO, John Kao, recently purchased 103,000 shares of the company's common stock in the open market.

General Atlantic's directors, David C. Hodgson and Nicholas Robbert Vorhoff, received 50,000 restricted stock units each in Alignment Healthcare, Inc. on March 13, 2024.

General Atlantic, a significant shareholder in Alignment Healthcare, reports the acquisition of restricted stock units by two of its employees who are directors of the Issuer.

Director Jeffrey H. Margolis reports acquiring 30,000 shares of Alignment Healthcare stock in a transaction dated March 13, 2024.

Director Margaret M. McCarthy acquired 33,500 restricted stock units in Alignment Healthcare, Inc. on March 13, 2024.

Hyong Kim, Chief Medical Officer of Alignment Healthcare, reports acquiring 158,970 shares of common stock through restricted stock units, discretionary awards, and shares in lieu of cash settlement.

Robert Scavo, Chief Information Officer of Alignment Healthcare, reports acquisition and disposal of company stock, including shares to cover tax obligations from vesting restricted stock units.

Director Yon Jorden of Alignment Healthcare, Inc. reports the acquisition of 30,000 restricted stock units and the disposal of 80,476 common stock shares.

Alignment Healthcare's CEO, John Kao, acquired 330,000 shares of common stock on March 13, 2024, and holds a total of 2,642,253 directly and 2,723,100 indirectly.

Chief People Officer of Alignment Healthcare, Andreas P. Wagner, reports the acquisition of 60,000 shares of common stock through restricted stock units.

Jacqueline B. Kosecoff, a director of Alignment Healthcare, acquired 40,000 restricted stock units on March 13, 2024.

Mark B. McClellan, a director at Alignment Healthcare, acquired 30,000 shares of common stock on March 13, 2024, in the form of restricted stock units.

Jody Bilney, a director of Alignment Healthcare, Inc., was granted 40,000 restricted stock units on March 13, 2024, which will vest on the one-year anniversary of the grant date, with deferred receipt of underlying shares until separation from service or a change of control.

Dawn Christine Maroney, President of Markets at Alignment Healthcare, reports acquisition and disposition of company stock, including shares to cover tax obligations.

Director Thomas J. Carella of Alignment Healthcare, Inc. acquired 40,000 restricted stock units on March 13, 2024.

Christopher Joyce, Chief Legal and Administrative Officer of Alignment Healthcare, reports acquiring 196,138 shares of common stock.

Director Nicholas Vorhoff of Alignment Healthcare received 50,000 restricted stock units, which will vest on the one-year anniversary of the grant date, but he disclaims beneficial ownership.

Robert Freeman, CFO of Alignment Healthcare, reports acquisition of shares through restricted stock units and sale of shares to cover tax obligations.

Joseph S. Konowiecki, Chairman of the Board of Alignment Healthcare, acquired 70,000 restricted stock units on March 13, 2024.

Hakan Kardes, Chief Experience Officer of Alignment Healthcare, sold 4,326 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.